155 related articles for article (PubMed ID: 24381140)
1. Association of ITGA3 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma.
Yang W; He M; Zhao J; Wang Z
Med Oncol; 2014 Feb; 31(2):826. PubMed ID: 24381140
[TBL] [Abstract][Full Text] [Related]
2. Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma.
Qi Y; Zhao C; Li H; Zhang B; Tada K; Abe H; Tada M
Tumour Biol; 2016 Jul; 37(7):9807-11. PubMed ID: 26810186
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Shi ZW; Wang JL; Zhao N; Guan Y; He W
Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
[TBL] [Abstract][Full Text] [Related]
4. Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population.
Wang K; Zhao J; He M; Fowdur M; Jiang T; Luo S
Tumour Biol; 2016 Jan; 37(1):1105-12. PubMed ID: 26276359
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 10 gene -1082A/G polymorphism is associated with osteosarcoma risk and poor outcomes in the Chinese population.
Cui Y; Zhu JJ; Ma CB; Cui K; Wang F; Ni SH; Zhang ZY
Tumour Biol; 2016 Apr; 37(4):4517-22. PubMed ID: 26503210
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors.
Sun XH; Hou WG; Zhao HX; Zhao YL; Ma C; Liu Y
Asian Pac J Cancer Prev; 2013; 14(3):2049-52. PubMed ID: 23679317
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.
Ru JY; Cong Y; Kang WB; Yu L; Guo T; Zhao JN
Int J Clin Exp Pathol; 2015; 8(3):3198-203. PubMed ID: 26045840
[TBL] [Abstract][Full Text] [Related]
8. Correlation between TGF-β1 gene 29 T > C single nucleotide polymorphism and clinicopathological characteristics of osteosarcoma.
Wu Y; Zhao J; He M
Tumour Biol; 2015 Jul; 36(7):5149-56. PubMed ID: 25663491
[TBL] [Abstract][Full Text] [Related]
9. PIK3CA and AKT gene polymorphisms in susceptibility to osteosarcoma in a Chinese population.
He ML; Wu Y; Zhao JM; Wang Z; Chen YB
Asian Pac J Cancer Prev; 2013; 14(9):5117-22. PubMed ID: 24175786
[TBL] [Abstract][Full Text] [Related]
10. Association between CTLA-4 genetic polymorphisms and susceptibility to osteosarcoma in Chinese Han population.
He J; Wang J; Wang D; Dai S; Yv T; Chen P; Ma R; Diao C; Lv G
Endocrine; 2014 Mar; 45(2):325-30. PubMed ID: 24078408
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
Wang G; Shen N; Cheng L; Lin J; Li K
Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
[TBL] [Abstract][Full Text] [Related]
12. Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy.
Zhang SL; Mao NF; Sun JY; Shi ZC; Wang B; Sun YJ
Asian Pac J Cancer Prev; 2012; 13(6):2705-9. PubMed ID: 22938445
[TBL] [Abstract][Full Text] [Related]
13. Predictive impact of common variations in DNA repair genes on clinical outcome of osteosarcoma.
Bai SB; Chen HX; Bao YX; Luo X; Zhong JJ
Asian Pac J Cancer Prev; 2013; 14(6):3677-80. PubMed ID: 23886164
[TBL] [Abstract][Full Text] [Related]
14. Association between H19 polymorphisms and osteosarcoma risk.
He TD; Xu D; Sui T; Zhu JK; Wei ZX; Wang YM
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3775-3780. PubMed ID: 28975992
[TBL] [Abstract][Full Text] [Related]
15. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of interleukin-1 beta and osteosarcoma risk.
He Y; Liang X; Meng C; Shao Z; Gao Y; Wu Q; Liu J; Wang H; Yang S
Int Orthop; 2014 Aug; 38(8):1671-6. PubMed ID: 24878968
[TBL] [Abstract][Full Text] [Related]
17. Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.
Hattinger CM; Biason P; Iacoboni E; Gagno S; Fanelli M; Tavanti E; Vella S; Ferrari S; Roli A; Roncato R; Giodini L; Scotlandi K; Picci P; Toffoli G; Serra M
Oncotarget; 2016 Sep; 7(38):61970-61987. PubMed ID: 27566557
[TBL] [Abstract][Full Text] [Related]
18. Genetic Variant of
Xu L; Ni J; Wang Y; Dong Y; Wang S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819874802. PubMed ID: 31522615
[TBL] [Abstract][Full Text] [Related]
19. Associations of polymorphisms in the bone morphogenetic protein-2 gene with risk and prognosis of osteosarcoma in a Chinese population.
Cong Y; Li CJ; Zhao JN; Liu XZ; Shi X
Tumour Biol; 2015 Mar; 36(3):2059-64. PubMed ID: 25391427
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in COL18A1 influence the development of osteosarcoma.
Guo Z; Zhang T; Wu J; Wang H; Liu X; Tian L
Int J Clin Exp Pathol; 2015; 8(9):11531-6. PubMed ID: 26617886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
